Arenas, V.; Castaño, J.L.; DomÃnguez, J.J.; Yáñez, L.; Pipaón, C.
Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. Cancers 2025, 17, 533.
https://doi.org/10.3390/cancers17030533
AMA Style
Arenas V, Castaño JL, DomÃnguez JJ, Yáñez L, Pipaón C.
Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. Cancers. 2025; 17(3):533.
https://doi.org/10.3390/cancers17030533
Chicago/Turabian Style
Arenas, VÃctor, Jose Luis Castaño, Juan José DomÃnguez, Lucrecia Yáñez, and Carlos Pipaón.
2025. "Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo" Cancers 17, no. 3: 533.
https://doi.org/10.3390/cancers17030533
APA Style
Arenas, V., Castaño, J. L., DomÃnguez, J. J., Yáñez, L., & Pipaón, C.
(2025). Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. Cancers, 17(3), 533.
https://doi.org/10.3390/cancers17030533